secwatch.observer — SEC 8-K summary
======================================

Issuer:     60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK:        0001946563
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001213900-23-083513
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

60 Degrees Pharmaceuticals receives Nasdaq deficiency notice for bid price non-compliance
--------------------------------------------------------------------------------

- On Nov 2, 2023, Nasdaq notified SXTP that its common stock failed to maintain minimum $1.00 closing bid price for 30 consecutive business days through Nov 1, 2023.
- The company has a 180-day compliance period until April 30, 2024 to regain compliance with the Bid Price Rule.
- If not compliant by April 30, 2024, SXTP may be eligible for an additional 180-day period if it meets other listing standards.
- Failure to regain compliance may result in delisting of common stock and warrants from Nasdaq Capital Market.
- The company is evaluating options to regain compliance, including potential reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/0001213900-23-083513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/ea187691-8k_60degrees.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-083513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer